Dipharma

Overview

Dipharma is a global Contract Development and Manufacturing Organisation (CDMO) and leading manufacturer of Active Pharmaceutical Ingredients (APIs). As a third-generation family-owned company, Dipharma operates 4 cGMP plants with commercial offices in Italy, U.S.A., and China, supported by approximately 600 employees.

Core Capabilities

Exclusive Synthesis Services: Dipharma provides custom synthesis and development services for pharmaceutical clients, leveraging more than 75 years of expertise in safely handling hazardous chemical processes using state-of-the-art technologies.

Catalogue APIs: The company manufactures and distributes a range of Active Pharmaceutical Ingredients through its catalogue offering, serving the generic pharmaceutical market.

Quality & Regulatory

Dipharma operates under stringent quality and safety standards with GMP compliance inspected by US-FDA, AIFA, PMDA, and other regulatory authorities since 1970. The organization maintains a robust quality management system including Six Sigma programs, root cause analysis (RCA), failure mode and effects analysis (FMEA), and lean continuous improvement initiatives.

Operational Strengths

• Stability & Experience: 75+ years in chemical process manufacturing with 250+ patents/applications filed and over 1,200 scientific publications
• Global Reach: Multi-site manufacturing with product validation across 2 manufacturing sites; ability to insource/outsource intermediates
• Innovation: Dedicated R&D and process development capabilities with process technologists and debottlenecking expertise
• Intellectual Property: Dedicated IP department supporting customer confidentiality and patent protection
• Workforce: Loyal, skilled employee base with extensive industry expertise in chemical and pharmaceutical manufacturing